0 citations
PDG82 Machine Learning to Identify Diabetes Patients with Canagliflozin Prescriptions at High-Risk of Lower Extremity Amputation Using Real-Word DATA
Value in Health2020Vol. 23, pp. S532–S532
Citations Over Time
Related Papers
- → Canagliflozin for the treatment of type 2 diabetes: a comparison between Japanese and non-Japanese patients(2018)17 cited
- → Abstract #262 Effects of Canagliflozin (CANA) On Hba1c and Changes in AHAS in the Canagliflozin Cardiovascular Assessment Study (CANVAS) Program(2018)2 cited
- → Canagliflozin(2014)1 cited
- → PDB64 COST-EFFECTIVENESS OF CANAGLIFLOZIN TREATMENT IN CHINESE PATIENTS WITH TYPE 2 DIABETES AND KIDNEY DISEASE(2019)
- → A real-world retrospective evaluation of glycaemic control and weight loss in patients with type 2 diabetes mellitus treated with canagliflozin 100 mg and canagliflozin 300 mg in an Indian setting(2020)